BioSpace News Archive

CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy Research Agreement with UMass Medical School

TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced that Ian Somaiya, Chief Financial Officer of TCR 2 Therapeutics, will present an update on Company progress at two upcoming conferences in September using a virtual platform. H.C. Wainwright 22 nd Annual Global Investment Conference on September 14, 2020 at 12:30pm

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced a successful Type A meeting with the U.S. Food and Drug Administration (FDA) in which alignment w

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that John Melo , President and Chief Executive Officer, will present during the H.C. Wainwright 22nd Annual Global I

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today announced the publication of medical technologies guidance for the Axonics r-SNM System by the National Institute for Health and Care Excellence (NICE).

9 Meters Biopharma, Inc., announced that management will participate in the following conferences in the month of September and invites investors to participate by webcast.

ValGenesis, Inc., a market leader in paperless validation solutions, announced that its Validation Lifecycle Management System supports Augmented Reality for remote and hands-free validation, to improve efficiency, data integrity, and compliance in the corporate validation process.

OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl, Chief Executive Officer, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Dave Bailey, President, are scheduled to participate in the Morgan Stanley 18 th Annual Global Healthcare Conference on Tuesday, September 15, 2020. Event: M

CavoGene LifeSciences, a biotechnology company committed to individuals worldwide who are impacted by various neurodegenerative diseases, is pleased to announce the appointment of Daniel Jorgensen, MD, MPH, MBA as the company’s Chief Executive Officer.

Investment from Playground Global and Fifty Years will Accelerate Development of Proprietary Technology to Enable Greater Throughput and Efficiency in Protein Therapeutics Development BOSTON--( BUSINESS WIRE )-- Manifold Bio , a spinout from George Church’s lab at Harvard Medical School focused on dramatically increasing the throughput of protein therapeutics testing in vivo , announced today the close of a $5.4 million Series Seed investment round.